Canadian journal of anaesthesia = Journal canadien d'anesthésie
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Remifentanil with morphine transitional analgesia shortens neurological recovery compared to fentanyl for supratentorial craniotomy.
To compare the recovery profiles, efficacy and safety of remifentanil and morphine for transitional analgesia with fentanyl in patients undergoing elective craniotomy for supratentorial mass lesions. ⋯ Remifentanil is a suitable alternative to fentanyl in supratentorial craniotomy. Time to preoperative neurological recovery is faster and morphine provides some transitional analgesia without compromising the quality of recovery.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Best evidence in anesthetic practice: prevention: epidural anesthesia and analgesia does not reduce 30-day all-cause mortality and major morbidity after abdominal surgery.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
P6 acupressure may relieve nausea and vomiting after gynecological surgery: an effectiveness study in 410 women.
To investigate the effect of sensory stimulation of the P6 point on postoperative nausea and vomiting (PONV) after gynecological surgery in the everyday clinical setting (effectiveness study). ⋯ P6 acupressure is a non-invasive method that may have a place as prophylactic antiemetic therapy during gynecological surgery.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Best evidence in anesthetic practice. Prevention: supplemental oxygen reduces the incidence of surgical-wound infection.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
To compare the new hydroxyethyl starch HES 130/0.4 (Voluven) and the standard HES 200/0.5 (pentastarch) regarding effectiveness for plasma volume substitution and safety of large volumes in heart surgery. ⋯ Hydroxyethyl starch 130/0.4 is an effective plasma volume expander in heart surgery and may be used as the sole artificial colloid to cover the perioperative period. We found a reduced influence of HES 130/0.4 on the physiologic postoperative increase of vWF.